Explore the words cloud of the Bio4Med project. It provides you a very rough idea of what is the project "Bio4Med" about.
The following table provides information about the project.
Coordinator |
INSTYTUT BIOLOGII DOSWIADCZALNEJ IM. M. NENCKIEGO POLSKIEJ AKADEMII NAUK
Organization address contact info |
Coordinator Country | Poland [PL] |
Project website | http://www.bio4med.nencki.gov.pl |
Total cost | 4˙604˙160 € |
EC max contribution | 2˙302˙080 € (50%) |
Programme |
1. H2020-EU.1.3.4. (Increasing structural impact by co-funding activities) |
Code Call | H2020-MSCA-COFUND-2014 |
Funding Scheme | MSCA-COFUND-DP |
Starting year | 2015 |
Duration (year-month-day) | from 2015-05-01 to 2020-04-30 |
Take a look of project's partnership.
The major aim of Bio4Med (Biology for Medicine) programme is to provide unique, international, inter-disciplinary and inter-sectoral doctoral training for Early Stage Researchers (ESRs) in the domain of biological bases of human diseases. To achieve this goal it combines 22 leading research groups at the Nencki Institute and their scientific partners from world-class laboratories located in EU Member States, Switzerland, Ukraine, Japan, Canada and US. Research programme includes basic science PhD-projects focused on molecular basis of neurodegeneration, neurological disorders, cancer and metabolic diseases. All supervising researchers engaged in the Bio4Med are at the international forefront of biomedical research and have experience in PhD student supervision. Our programme will foster young researchers’ career development and employability by addressing the following objectives: (i) to offer excellent training in modern biology and endow ESRs with unique scientific knowledge, and experience in cutting-edge experimental techniques; (ii) to enhance research-oriented and transferable skills of ESRs; (iii) to promote scientific mobility via international, inter-disciplinary and inter-sectoral collaboration. The objectives of Bio4Med will be delivered through activities encompassing practical laboratory training, hands-on workshops, lectures corresponding to the theoretical aspects of doctoral projects, research-oriented generic skills courses, transferrable skills courses, progress talks and meetings. The training programme itself, focused on medically important issues, will make ESRs highly attractive to commercial enterprises, particularly in biotechnology and pharmaceutical sectors. Bio4Med programme will increase the regional, national as well as EU competitiveness by providing a new generation of visionary and innovative researchers able to transform basic science into healthcare solutions.
2nd Report on dissemination activities | Documents, reports | 2019-07-30 14:08:45 |
Researcher Declaration | Documents, reports | 2019-05-30 12:07:24 |
1st Periodic Report | Documents, reports | 2019-05-30 12:07:26 |
Link to the Call in the EURAXESS website | Websites, patent fillings, videos etc. | 2019-05-30 12:07:31 |
1st Report on dissemination activities | Documents, reports | 2019-05-30 12:07:32 |
Take a look to the deliverables list in detail: detailed list of Bio4Med deliverables.
year | authors and title | journal | last update |
---|---|---|---|
2017 |
Krzysztof M. Bernadzki, Marta Gawor, Marcin Pęziński, Paula Mazurek, Paweł Niewiadomski, Maria J. Rędowicz, Tomasz J. Prószyński Liprin-α-1 is a novel component of the murine neuromuscular junction and is involved in the organization of the postsynaptic machinery published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-017-09590-7 |
Scientific Reports 7/1 | 2018-07-10 |
2017 |
Margaret Nieborowska-Skorska, Silvia Maifrede, Yashodhara Dasgupta, Katherine Sullivan, Sylwia Flis, Bac Viet Le, Martyna Solecka, Elizaveta A. Belyaeva, Lucia Kubovcakova, Morgan Nawrocki, Martin Kirschner, Huaqing Zhao, Josef T. Prchal, Katarzyna Piwocka, Alison R. Moliterno, Mariusz Wasik, Steffen Koschmieder, Tony R. Green, Radek C. Skoda, Tomasz Skorski Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms published pages: blood-2017-05-78, ISSN: 0006-4971, DOI: 10.1182/blood-2017-05-784942 |
Blood | 2018-07-10 |
2017 |
Siranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad J. Dębski, Joanna Wojsiat, Michał Dąbrowski, Tomasz Gabryelewicz, Jacek Kuźnicki, Urszula Wojda Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects published pages: , ISSN: 1949-2553, DOI: 10.18632/oncotarget.15109 |
Oncotarget | 2018-07-10 |
2017 |
Silvia Maifrede, Esteban Martinez, Margaret Nieborowska-Skorska, Daniela Di Marcantonio, Michael Hulse, Bac Viet Le, Huaqing Zhao, Katarzyna Piwocka, Italo Tempera, Stephen M. Sykes, Tomasz Skorski MLL-AF9 leukemias are sensitive to PARP1 inhibitors combined with cytotoxic drugs published pages: 1467-1472, ISSN: 2473-9529, DOI: 10.1182/bloodadvances.2017006247 |
Blood Advances 1/19 | 2018-07-10 |
2017 |
Anna Mietelska-Porowska, Urszula Wojda T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer’s Disease: Potential Pools of New Biomarkers published pages: 1-17, ISSN: 2314-8861, DOI: 10.1155/2017/4626540 |
Journal of Immunology Research 2017 | 2018-07-10 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIO4MED" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BIO4MED" are provided by the European Opendata Portal: CORDIS opendata.